Laxmi Organic Industries Ltd

Laxmi Organic Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Laxmi Organic Industries Ltd

₹ 197 -1.06%
18 Jul - close price
laxmi.com BSE: 543277 NSE: LXCHEM
About

Laxmi Organic Industries Limited was established in 1989 and is in the business of specialty chemicals. The Company primarily manufactures Ethyl Acetate, Acetic Acid and Diketene Derivative Products (DDP). DDP is a specialty chemical group, the technology and business of which has been acquired by the company from Clariant Chemicals India Limited.
The company’s business operations are carried in over 30 countries including 11 offices located in India

Key Points

Product Portfolio[1]
a) Essentials Segment
The Segment includes products like Ethyl Acetate, Acetic Anhydride, Acetaldehyde, various solvents, ethanol, and n-Butyl/Ethyl Acetate. These cater primarily to the pharmaceutical, packaging, and industrial sectors.

Website BSE NSE
  • Market Cap ₹ 5,466 Cr.
  • Current Price ₹ 197
  • High / Low ₹ 326 / 160
  • Stock P/E 49.8
  • Book Value ₹ 68.8
  • Dividend Yield 0.25 %
  • ROCE 8.56 %
  • ROE 5.93 %
  • Face Value ₹ 2.00
Edit ratios

Pros

Cons

  • Stock is trading at 2.87 times its book value
  • Company has a low return on equity of 7.31% over last 3 years.
  • Dividend payout has been low at 12.2% of profits over last 3 years
  • Promoter holding has decreased over last 3 years: -3.54%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals

Part of BSE SmallCap BSE Allcap BSE Commodities Nifty Microcap 250 Nifty Total Market

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
880 757 652 655 730 729 652 694 792 718 771 786 710
795 656 624 600 672 652 613 642 702 647 697 712 651
Operating Profit 85 100 29 55 58 77 39 52 90 71 75 75 59
OPM % 10% 13% 4% 8% 8% 11% 6% 8% 11% 10% 10% 10% 8%
2 2 3 3 7 4 8 5 8 12 7 6 1
Interest 5 2 4 6 -1 5 2 1 -1 3 8 2 7
Depreciation 13 14 17 19 23 21 28 28 31 26 27 31 40
Profit before tax 69 87 10 34 43 56 18 30 68 54 46 47 13
Tax % -1% 26% 15% 19% 43% 31% 39% 8% 35% 36% 39% 38% -64%
70 64 9 27 24 38 11 27 44 34 28 29 22
EPS in Rs 2.65 2.43 0.32 1.03 0.92 1.44 0.40 0.99 1.61 1.24 1.02 1.06 0.79
Raw PDF
Upcoming result date: 28 July 2025

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
1,074 1,047 1,076 1,376 1,569 1,534 1,768 3,084 2,791 2,865 2,985
988 966 957 1,222 1,414 1,418 1,548 2,713 2,548 2,609 2,699
Operating Profit 86 80 119 154 155 117 220 371 243 256 286
OPM % 8% 8% 11% 11% 10% 8% 12% 12% 9% 9% 10%
1 2 2 3 6 30 4 15 18 28 19
Interest 26 19 11 12 19 17 19 19 15 7 20
Depreciation 30 29 28 31 44 49 47 48 72 107 124
Profit before tax 31 34 82 113 98 81 158 319 173 171 161
Tax % 31% 22% 13% 33% 26% 13% 20% 19% 28% 29% 29%
21 27 72 76 72 70 127 257 125 121 114
EPS in Rs 21.12 26.56 71.50 75.63 14.46 15.57 4.82 9.76 4.70 4.37 4.10
Dividend Payout % 0% 0% 0% 0% 0% 11% 10% 7% 11% 14% 12%
Compounded Sales Growth
10 Years: 11%
5 Years: 14%
3 Years: -1%
TTM: 4%
Compounded Profit Growth
10 Years: 18%
5 Years: 17%
3 Years: -25%
TTM: -6%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: -15%
1 Year: -22%
Return on Equity
10 Years: 12%
5 Years: 11%
3 Years: 7%
Last Year: 6%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 10 10 10 10 50 45 53 53 53 55 55
Reserves 199 225 295 369 400 382 982 1,237 1,359 1,742 1,851
249 221 104 215 175 159 149 139 406 143 258
152 176 240 300 389 484 654 820 595 887 880
Total Liabilities 610 632 649 895 1,014 1,069 1,838 2,249 2,412 2,827 3,045
226 215 202 293 346 338 325 379 715 879 1,166
CWIP 25 40 61 30 31 67 148 374 447 444 398
Investments 0 0 0 0 0 0 3 5 23 126 148
358 377 386 571 637 664 1,361 1,492 1,228 1,378 1,332
Total Assets 610 632 649 895 1,014 1,069 1,838 2,249 2,412 2,827 3,045

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
80 150 -7 188 196 106 65 199 561 108
-21 -37 -85 -123 -56 -641 76 -384 -490 -268
-57 -107 85 -63 -123 527 -124 232 -42 90
Net Cash Flow 1 6 -7 2 16 -7 17 47 30 -70

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 64 67 79 86 76 86 90 79 75 74 66
Inventory Days 37 57 37 55 57 51 63 64 58 54 71
Days Payable 52 67 85 81 105 138 148 122 92 145 131
Cash Conversion Cycle 49 56 30 60 28 -1 5 21 41 -16 6
Working Capital Days 65 66 36 65 43 25 27 58 66 24 38
ROCE % 12% 22% 25% 19% 12% 20% 26% 12% 9% 9%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
72.52% 72.51% 72.50% 72.50% 72.39% 72.39% 69.83% 69.71% 69.55% 69.50% 69.39% 69.39%
0.60% 0.45% 0.45% 0.47% 0.48% 0.48% 0.67% 0.85% 1.05% 1.67% 1.97% 2.48%
3.22% 1.62% 1.65% 1.73% 1.54% 1.55% 3.53% 3.43% 2.16% 3.22% 3.47% 3.38%
23.66% 25.42% 25.40% 25.30% 25.59% 25.58% 25.97% 26.00% 27.25% 25.61% 25.17% 24.75%
No. of Shareholders 4,40,4464,76,9284,73,4114,64,9384,55,3374,52,2924,48,0684,28,1844,20,5093,87,4893,80,0593,76,136

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls